Related Experiment Video
Updated: Oct 28, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors
1Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill 27599, USA.
Abstract:
Apoptosis induced by the p53 tumor suppressor can attenuate cancer growth in preclinical animal models. Inactivation of the pRb proteins in mouse brain epithelium by the T121 oncogene induces aberrant proliferation and p53-dependent apoptosis. p53 inactivation causes aggressive tumor growth due to an 85% reduction in apoptosis. Here, we show that E2F1 signals p53-dependent apoptosis since E2F1 deficiency causes an 80% apoptosis reduction. E2F1 acts upstream of p53 since transcriptional activation of p53 target genes is also impaired. Yet, E2F1 deficiency does not accelerate tumor growth. Unlike normal cells, tumor cell proliferation is impaired without E2F1, counterbalancing the effect of apoptosis reduction. These studies may explain the apparent paradox that E2F1 can act as both an oncogene and a tumor suppressor in experimental systems.
Insights
The E2F1 protein signals p53-dependent apoptosis, crucial for controlling tumor growth. Its deficiency reduces apoptosis but also impairs tumor cell proliferation, creating a complex role in cancer.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Research
Background:
- The p53 tumor suppressor induces apoptosis, a key mechanism for attenuating cancer growth.
- Inactivation of pRb proteins by the T121 oncogene in mouse brain epithelium leads to aberrant proliferation and p53-dependent apoptosis.
- p53 inactivation results in aggressive tumor growth due to a significant reduction in apoptosis.
Purpose of the Study:
- To investigate the role of E2F1 in signaling p53-dependent apoptosis.
- To determine the impact of E2F1 deficiency on tumor growth and proliferation.
- To elucidate the paradoxical functions of E2F1 as both an oncogene and tumor suppressor.
Main Methods:
- Utilizing mouse models with specific genetic manipulations (T121 oncogene, E2F1 deficiency).
- Quantifying apoptosis rates and assessing tumor growth.
- Analyzing the transcriptional activation of p53 target genes.
Main Results:
- E2F1 deficiency caused an 80% reduction in apoptosis, indicating its role in signaling p53-dependent cell death.
- E2F1 acts upstream of p53, as evidenced by impaired transcriptional activation of p53 target genes.
- Despite reduced apoptosis, E2F1 deficiency did not accelerate tumor growth because it also impaired tumor cell proliferation.
Conclusions:
- E2F1 is a critical upstream regulator of p53-dependent apoptosis.
- The dual effect of E2F1 on apoptosis and proliferation explains its context-dependent role in tumor development.
- These findings contribute to understanding the complex interplay between cell death, proliferation, and oncogenesis.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle

